AstraZeneca AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
21 Pages - GLDATA62568
$250.00

Summary

AstraZeneca AB (AstraZeneca), a subsidiary of AstraZeneca plc is a pharmaceutical service provider that manufactures and distributes pharmaceutical products. The company research, produces and markets products in heart and cardiovascular, infection, cancer, metabolic diseases, respiratory, stomach and intestinal, oncology, inflammation and autoimmunity and in other areas. Its portfolio of investigational therapies has varied stages of clinical development. AstraZeneca markets its products through its network of distributors across the world. The company operates through offices located in Denmark, Norway, Finland, Iceland, Estonia, Latvia and Lithuania. It operates in Gothenburg and Sodertalje. AstraZeneca is headquartered in Stockholm, Sweden.

AstraZeneca AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
AstraZeneca AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AstraZeneca AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AstraZeneca AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AstraZeneca AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
AstraZeneca AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
AstraZeneca AB, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Horizon Pharma To Acquire US Rights To Vimovo From Pozen 10
Partnerships 11
Cerulean Pharma and AstraZeneca Enter into Research Agreement with National Cancer Institute 11
Hutchison MediPharma Enters into Agreement with AstraZeneca 12
Alchemia Enters Into Drug Discovery Agreement With AstraZeneca 12
Orexo Enters Into Research Agreement With AstraZeneca For OX-CLI Program 13
Licensing Agreements 14
Insmed Enters into Licensing Agreement with AstraZeneca 14
Equity Offering 16
Regulus Therapeutics Completes Private Placement Of Shares For US$25 Million 16
Asset Transactions 16
BiQ Pharma Acquires Research Facility from AstraZeneca 16
AstraZeneca AB - Key Competitors 18
Key Employees 19
Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
AstraZeneca AB, Pharmaceuticals & Healthcare, Key Facts 1
AstraZeneca AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AstraZeneca AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AstraZeneca AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AstraZeneca AB, Deals By Therapy Area, 2011 to YTD 2017 8
AstraZeneca AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Horizon Pharma To Acquire US Rights To Vimovo From Pozen 10
Cerulean Pharma and AstraZeneca Enter into Research Agreement with National Cancer Institute 11
Hutchison MediPharma Enters into Agreement with AstraZeneca 12
Alchemia Enters Into Drug Discovery Agreement With AstraZeneca 12
Orexo Enters Into Research Agreement With AstraZeneca For OX-CLI Program 13
Insmed Enters into Licensing Agreement with AstraZeneca 14
Regulus Therapeutics Completes Private Placement Of Shares For US$25 Million 16
BiQ Pharma Acquires Research Facility from AstraZeneca 16
AstraZeneca AB, Key Competitors 18
AstraZeneca AB, Key Employees 19

List of Figures
AstraZeneca AB, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
AstraZeneca AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
AstraZeneca AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
AstraZeneca AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
AstraZeneca AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AstraZeneca AB, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
AstraZeneca AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AstraZeneca AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838